The Brazil injectable drugs market comprises pharmaceutical preparations that are delivered to the body via parenteral administration routes like intravenous, subcutaneous, intramuscular and other routes. Injectable drugs provide immediate and targeted delivery of medications for various indications like cancer, diabetes, musculoskeletal disorders and others. They offer advantages like faster onset of action, improved bioavailability and reduced risk of gastrointestinal irritation. The growing geriatric population suffering from chronic conditions in Brazil is increasing the demand for such drugs for effective disease management.
The global Brazil Injectable Drugs Market is estimated to be valued at US$ 9353.45 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing geriatric population is one of the major trends fueling the growth of the Brazil injectable drugs market. As per WHO estimates, Brazil has one of the largest aging populations in Latin America. It is projected that around 30% of Brazil’s population will be aged 60 years and above by 2050. The aged citizens are more susceptible to chronic diseases like diabetes, cancer, cardiovascular conditions which require long term management with injectable drugs. Furthermore, self-injection or at-home administration for conditions like infertility, rheumatoid arthritis and others is gaining popularity over hospital-based treatments. This increases treatment convenience and compliance while reducing healthcare costs. Such evolving trends are expected to support the growth of Brazil injectable drugs market during the forecast period.
SWOT Analysis
Strength: Brazil has a large population and growing economy which increases the demand for healthcare services in the country. Government initiatives to improve access to healthcare also drives demand.
Weakness: Prevalence of counterfeit drugs poses safety issues. High taxation on medicines impact affordability. Reliance on imported raw materials increases production costs.
Opportunity: Rapid urbanization and lifestyle changes are resulting in increased incidence of chronic diseases. Growing medical tourism due to world-class facilities presents an opportunity.
Threats: Price control policies affect profit margins of manufacturers. Strict regulatory norms for approval of new drugs delays market entry. Economic uncertainties impact healthcare spending.
Key Takeaways
The Brazil Injectable Drugs Market Analysis for hospitals & ambulatory settings is expected to witness steady growth over the forecast period backed by rising healthcare expenditure in the country. The market size for injectable drugs in Brazil was valued at US$ 9353.45 Mn in 2023 and is expected to reach US$ 13459.72 Mn by 2030, expanding at a CAGR of 4.6%.
Regional Analysis
The Southeast region dominates the Brazil injectable drugs market, accounting for over 30% share in 2023. States like Sao Paulo and Rio de Janeiro are the major revenue generators owing to concentration of private healthcare facilities and hospitals. Growing medical tourism is also boosting the market in Southeast regions. The Northeast region is expected to witness highest growth during the forecast period backed by government initiatives to strengthen healthcare infrastructure in the region.
Key Players
Key players operating in the Brazil injectable drugs market for hospitals & ambulatory settings are Amcor Limited, Bemis Company, Sealed Air Corporation, Berry Plastics Group, Inc., Mondi Group, Sonoco Products Co., Huhtamäki Oyj, Constantia Flexibles Gmbh, Ampac Holdings, Llc, Bischof + Klein International, Wipak Group, AR Packaging, Goglio Group, Schur Flexibles, Clondalkin Group, Flair Flexible Packaging Solution Cellpack Packaging, and Südpack Verpackungen. The market is fairly competitive with top firms focusing on new product launches and capacity expansion to strengthen their position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.